This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

CRA Oncology experts
Industries

Oncology

Oncology consulting with cutting-edge strategies and comprehensive expertise

The treatment, policies, and study of oncology continue to undergo rapid changes and evolution, with each year bringing new opportunities and challenges for existing and new treatments. CRA positions itself on the cutting edge of the field, staying abreast of the latest issues and developments and allowing us to provide actionable, future-focused strategies for our clients.

CRA’s knowledge base stems from hundreds of engagements on solid and hematological tumors, working with clients on small molecules, monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), cell therapies, oncology vaccines, and the increasing range of combination approaches to treating cancer.

Why CRA for your strategic partner in oncology?

Engagements

  • 01
    Evaluating unintended impacts of the IRA’s Medicare Drug Price Negotiation Program on small and large molecule medicines
    A leading pharmaceutical company sought support from CRA Life Sciences experts in analyzing the patient, health system, and innovation implications of the IRA's
    View engagement
  • 02
    Developing an evidence-based framework for sustainable NCCP funding and address global disparities in implementation and outcomes
    A leading pharmaceutical company sought CRA Life Sciences experts to gain a deeper understanding of how governments plan and finance national cancer strategies
    View engagement
  • 03
    Developing market-access focused segmentation and typing tool to aid uptake of bispecific oncology products
    A leading pharmaceutical company sought support from CRA’s Life Sciences consultants in understanding how to best segment, target, and activate key access
    View engagement
See more Oncology engagements

Contact an Oncology expert.

See all Oncology experts

Latest insights

See all Oncology insights

Recent events

See all Oncology events

Subscribe to receive our latest Insights.

Subscribe